# DIAZEPAM
> **ANDA211998** · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2019-12-26
## Drug
- **FDA Application Number:** ANDA211998
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DIAZEPAM
- **Generic name:** DIAZEPAM
- **Active ingredients:** DIAZEPAM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** REGCON HOLDINGS
- **Manufacturer:** Natco Pharma USA LLC
- **First approval:** 2019-12-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211998)
---
*AI Analytics · CC0 1.0*